← Mandate Registry · 7 mandate layers · pharma
healthcare · FDA 21 CFR Part 11 · GCP ICH E6 · EU AI Act Annex III
Pharma / Clinical Trials
21 CFR Part 11 already requires what Velaru does — not AI safety, compliance
—EU AI Act Annex III — healthcare/life sciences
Regulatory exposure — commonly overlooked:
Sponsors using vendor AI for protocol deviation detection — sponsor owns FDA finding, vendor owns nothing.
483 observations
FDA inspection: show audit trail for AI-flagged deviation — altered records = criminal referral pattern.
ICH E6 GCP
AI-assisted monitoring must be in validation documentation — post-hoc PowerPoint fails.
Trial insurance
Clinical trial insurers now ask AI governance questionnaire — receipts beat questionnaires.
7 mandate layers (live)
Regulatory Clock
Countdown to operative regulatory deadline — NAIC adoption, GSE mandate, EU transposition.
Open →
Domain Classifier
Industry-specific SAFE/CRISIS/VIOLATION with regulatory framework mapping.
Open →
Exhibit / Filing Pack
Regulator-ready external validation — NAIC Exhibit D, Fannie QC, EU FRIA, FDA Part 11.
Open →
Mandate Registry
Enroll deployers/insureds under vertical-specific governance mandate.
Open →
Bind / Action Gate
ALLOW/BLOCK before consequential action — bind policy, sell loan, deactivate worker.
Open →
Compliance Certificate
Deployer-facing downloadable cert — forward to counsel, auditor, regulator.
Open →
Actuarial / Risk Feed
Anonymized asymmetry signals for pricing, reserving, reinsurance correlation.
Open →